Friday, July 31, 2026

Samsung Biologics Expands Global Reach: New European Sales Office Set to Boost Biopharmaceuticals Market

Samsung Biologics expands its global sales network with a new office in Europe, aiming for growth in production and portfolio diversification.

Kim Jong Un Hosts Three-Day Meeting, Pushes for Economic Upgrades

North Korea's Workers' Party held a plenary meeting to assess policies, discuss economic plans, and address organizational matters.

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

Tag: biotechnology

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

EuBiologics Registers EcML Adjuvant Platform With U.S. FDA Drug Master File

EuBiologics' EcML™ vaccine adjuvant platform has been registered with the FDA, enhancing immunogenicity and enabling global collaborations.

Celltrion Expands PFS Production Capacity to 70 Million: What This Means for the Global Market

Celltrion Pharmaceutical plans to invest 2 trillion KRW to expand its pre-filled syringe production capacity to meet global demand.

Samsung Biologics Accelerates “Three-Pillar Expansion Strategy” With Peptide CDMO Acquisition to Drive Global Growth

Samsung Biologics acquires Polypeptide Group for $1.8 billion, expanding into the peptide CDMO market to enhance growth and capabilities.

[Interview] Excelthera Expands Portfolio With Immune Cell Culture Media, Accelerating Global Partnership Efforts

Excelthera aims to expand globally by launching new immune cell culture media and seeking global partners for collaboration.

U.S. pharmaceutical companies’ China clinical trial security probe to conclude this week… Could biotech rivalry intensify?

A U.S. investigation into pharmaceutical trials in China may reshape global biotech strategies, impacting South Korean firms.

Shaperon Secures South Korean Patent for Pulmonary Fibrosis Drug Candidate NuPulin

Shaperon secures a South Korean patent for NuPulin, an oral drug for idiopathic pulmonary fibrosis, showing promising preclinical results.

Interview: Huons’ PanGen Bets on ‘Development-Focused CDMO’ Strategy Built on Biosimilar Experience

South Korea's PanGen CDMO emphasizes development expertise and tailored services, enhancing drug development support for clients.

Lotte Biologics’ ‘Three Production Batches, 14% Utilization’ Underscores Need for New Orders Over New Plants

Lotte Biologics aims to enter the global CDMO market by expanding production, but faces challenges in securing contracts and profitability.

Inventage Lab to present mRNA-LNP large-scale manufacturing platform at CRS 2026

Inventage Lab showcases its IVL-GeneFluidic® platform for mRNA lipid nanoparticles at CRS 2026, enhancing local manufacturing capabilities.

K-Beauty to drive global growth through convergence with biotech and fashion, KHIDI official says [Moon Dae-hyun’s MediView]

K-beauty aims for growth by integrating with biotech, medical devices, and fashion, enhancing global competitiveness and sustainability.

Korea Rising: How South Korea is Shaping the Future of the Global Bioindustry at BIO International Convention 2026

Korea's bioindustry showcased its innovations at BIO USA 2026, emphasizing global collaboration and the need for diverse business models.

Big Pharma Turns to AI, China to Capital—What K-Bio Faced in San Diego [BIO USA Wrap-Up]

The BIO International Convention 2026 highlighted AI's role in biotech, emphasizing supply chain shifts and the need for capital investment.

Shaperon to Expand Biobeauty Business With NeedsTech, Targeting Hong Kong, Taiwan and U.S. Markets

Shaperon is acquiring NeedsTech to enhance its biobeauty business and expand globally, targeting markets in Hong Kong, Taiwan, and the U.S.

Samsung Biologics Expands Global Reach: New European Sales Office Set to Boost Biopharmaceuticals Market

Samsung Biologics expands its global sales network with a new office in Europe, aiming for growth in production and portfolio diversification.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.